Kidney Cancer Treatment Options at  The Kidney Cancer Institute

Active Surveillance

Laparoscopic Kidney Cryoablation /
Radiofrequency Ablation

Percutaneous Kidney Cryoablation /
Radiofrequency Ablation

Laparoscopic Partial Nephrectomy

DaVinci® Robotic Laparoscopic
Partial Nephrectomy

Open Partial Nephrectomy

Laparoscopic Radical Nephrectomy

Open Radical Nephrectomy

Laparoscopic Cytoreductive
Nephrectomy

Open Cytoreductive Nephrectomy

Open Nephrectomy with
Vena Caval Reconstruction

 
Biotechnology That is Used to Cure Kidney Cancer

 

 

Kidney Cancer Variants (Pathology)

Questions for Dr. Landman
 

Kidney cancer is NOT one disease.   Cancers of the kidney are actually a series of very different diseases that have different types of behavior.  While cancer is never totally predictable, the type of kidney cancer has a major impact on overall prognosis and the type of surveillance (follow-up) that a patient will require.  In the past, a physician may have referred to “kidney cancer” as a disease.  Today, it is clearly recognized as a group of different diseases and physicians divide these diseases into different categories.

In the past, the classification of kidney cancer was been based on “cytomorphological” characteristics.  Simply put, a small piece of the kidney cancer that was extracted was traditionally evaluated under a standard microscope.  The basic principles of microscopic evaluation of kidney cancers have changed little for a century. 

In 1996, an international group of experienced pathologist met in Heidelberg Germany to re-evaluate the manner in which kidney cancers are classified.  This group of pathologist combined traditional microscope findings with more advanced molecular studies to re-define kidney cancer types.  The published summary of this group’s findings is now known as the Heidelberg Classification.

The value of the Heidelberg consensus was that recent advances in our understanding of the genetic code underlying kidney cancer were incorporated into the thought process of physicians.  Indeed, it is the genetic changes in different kidney cancer types that results in the specific behavior of the disease.  Genetics affect the rate at which a kidney cancer will grow as well as the kidney cancer’s ability to spread to other parts of the body (metastasize).

The new understanding of the genetic changes which resulted in the creation of different types of kidney cancer allow for more precise stratification of the different types that exist.  The Heidelberg classification combines the traditional appearance of kidney cancer tissue under a microscope with genetic molecular classification to more precisely divide tumors.  This precise description of tumors allows physicians and patients to better understand and treat the different types of kidney cancer.  There are two major initial types of kidney cancer within the Heidelberg classification; benign and malignant kidney cancers. 

Benign Kidney Cancer Variants 
Generally, the definition of a benign tumor is that it does not have the ability to metastasize (spread via blood or lymphatic channels to other parts of the body).  Benign kidney cancers can still cause harm by growing and causing local damage to tissues.  However, compared to malignant kidney cancers, benign tumors are generally more easily cured.

Tumor Type Description Genetic Changes
Metanephric Adenoma

Metanephric Adenoma
Consists of tubules and tissues that are like the kidney tissue of a human embryo.  Previously known as ‘nephrogenic adenofibroma’ Unknown
Papillary Renal Cell Adenoma Mostly these tumors are incidental findings a the time of autopsy, or they are found in conjunction with papillary renal cell cancer variants in the tissue
that has been removed

Trisomy of chromosomes
7 and 17 and loss of the
Y chromosome

Oncocytoma
Oncocytoma
The most common of benign tumors removed by surgeons. 
The pattern of growth consists of typical oncocytic cells

Loss of chromosome arms 1p, 14q, and loss of the
y chromosome
or translocation of 11q13 to other chromosomes

Malignant Kidney Cancer Variants
A malignant tumor is defined as a tumor type that has the capacity to metastasize.  Malignant kidney cancer variants are more common than benign kidney cancer types and have the ability to spread via the bloodstream, lymphatic channels, or direct growth into other parts of the body.  With any kidney growth that is discovered, a physician performs a “staging evaluation” prior to treatment.  A staging evaluation is a series of blood and imaging (radiographic tests) to determine if the tumor may have spread beyond the confines of the kidney.

Malignant kidney cancer (Renal Cell Carcinoma) variants (Heidelberg Classification)

Carcinoma Variant Description Genetic Changes
Conventional
conventional
Most common type of kidney cancer making up about 75% of all tumors.  Originally known as ‘clear cell carcinoma’ as it is primarily composed of cells with a clear appearance Highly characteristic deletion on chromosome 3p known as the VHL gene.  Other changes include duplication of band 5q22 and deletions of chromosome arms 6q, 8p, and 14q

Papillary
Papillary

Accounts for approximately 10% of all kidney tumors and is characterized by a ‘papillary’ growth pattern. These tumors are frequently multifocal (more than one in a kidney) and may be bilateral (involve both kidneys)

Trisomy of chromosomes 3q, 7, 8, 12, 16, 17, and 20, and loss of the
Y chromosome are the most consistent changes

Chromophobe
chromophobe
Approximately 5% of all kidney growths and is has a pattern of solid sheets that are typically pale.  Loss of heterozygosity of chromosomes 1, 2, 6, 10, 13, 17, and 21.
Often has multiple copies of chromosomes.
Collecting Duct Carcinoma
collecting duct
A rare kidney cancer variant consisting of only about 1% of all kidney growths.  Microscopically appears to have irregular channels.  Unknown
Unclassified There are still a small number of kidney tumors that can not be classified under the microscope or by molecular genetic evaluation Unknown

 

 

Video Showcase

Cryoablation Video

Cryoablation Patient Interview

Cryoablation Patient Testimonial

Percutaneous Renal Cryoablation

Laparoscopic Partial Nephrectomy

Laparoscopic Radical         Nephrectomy

Robotic Partial Nephrectomy

Complementary Mangement Strategies

More details on metastatic how
kidney cancer spreads

What are the challenges in treating metastatic kidney cancer?

How does metastatic kidney cancer affect my body?

How common is metastatic kidney cancer?

Which organs are most likely to be affected by metastatic kidney cancer?

What is the prognosis of people with metastatic kidney cancer?

As a patient with metastatic kidney cancer, what should I do?

Treatment for Metastatic Kidney Cancer

Why is metastatic cancer worse than localized cancer?

How is metastatic kidney cancer treated?

En Espaņol

 

Copyright 2006 Kidney Cancer Institute            

Complementary Management Strategies | Biotechnology That is Used to Cure Kidney Cancer
Kidney Cancer Questions & Answers | About Dr. Landman | Questions for Dr. Landman

Find Us On Facebook

Website Design by Dynamic Digital Advertising
Site Guide

Home   Resources   References   News   Directions   Patient Testimonials   Contact Us

About Dr. Landman